We Present You Our Mission for a World with Better, Safer Drugs
Bridging the Artificial Intelligence Divide in Drug Discovery
We employ specially designed machine learning tools that replicate the human body’s biochemical actions. These tools offer deep insights into molecule selectivity as well as complex interactions within our biology, both exogenous and endogenous.
The cutting-edge approach to drug candidate curation takes place digitally, moving beyond traditional lab settings.
What sets GATC Health’s technology apart is the unbeatable combination of precision, rapidity, and affordability. Our technology shines in discovering new compounds, enhancing the efficacy of existing ones, and breathing life into previously unsuccessful compounds.
Elevenfold Superiority Over Industry
Our pre-clinical lead optimization outperforms traditional approaches and AI-assisted rivals elevenfold. We’re transforming pharmaceutical development, saving companies millions and trimming down years off each drug’s journey.
A Whopping 400 Trillion Points of Insight
Our system swiftly sifts through 400 trillion genetic markers—equivalent to 2,500 whole exomes—in only about 7 minutes. We’re turning big data into smart data.
Up to A Dozen Breakthroughs Annually
By generating 10 to 12 potential breakthrough drugs every year, we’re consistently creating value worth millions and pushing healthcare boundaries.
Cultivating a Wealth of Patents
Our growing treasure trove of patents covers everything from novel drug candidates across various fields (neurology, oncology, diabetes) to predictive health reports and diagnostics tools—all built on the strength of our MAT AI platform.
Drug Discovery
Our cutting-edge De Novo drug discovery method significantly accelerates the process from years to mere months. Complemented by speed, precision, and cost-effectiveness, diagnostic biomarkers are identified from a dataset and systematically assessed for cause and effect impacts.
Following validation, these biomarkers are simulated and evaluated using AI-assisted models and expert insights. This process results in a final set of treatment targets, shedding light on the disease’s intricacies. We then use in silico compound discovery to create novel treatment compounds.
Following this, the targets and compounds undergo prioritization for pre-clinical testing.
Drug Development
We support pharmaceutical manufacturers by de-risking, optimizing, and repurposing their IP while extending its value.
Our involvement spans pre-clinical to clinical trial support, prioritizing assets in development for ensuring greater commercial success. Additionally, we aid in the discovery of new assets across various therapeutic areas to expand the pipeline. We can reassess previously failed or shelved assets, to unearth the root cause of their failure and redirect them for potential success or sale.
With an impressive track record, our validation platform accurately predicts successful outcomes with 88% accuracy and failures with 84% accuracy.
Risk Prediction
Our cutting-edge AI tools harness genomic and multiomics data to offer predictive health insights to individuals and populations, thus transforming proactive healthcare.
The personalized risk reports generated provide actionable knowledge for better healthcare management.
Our precision services also enhance our partners’ offerings in personalized medicine. Additionally, the rich-data collected bolsters our AI’s drug discovery and optimization capabilities.
Get in Touch
We’re here to keep you informed. If you require further information, wish to connect with our media team, or seek insights about GATC Health, we’re just a click away.
Connect directly with our Media Team for press inquiries, interview requests, or any other media-related questions. They are ready and equipped to provide the information you require.
